2020
DOI: 10.3389/fped.2020.00443
|View full text |Cite
|
Sign up to set email alerts
|

High-Throughput Sequencing Reveals the Loss-of-Function Mutations in GALT Cause Recessive Classical Galactosemia

Abstract: Background: Classical Galactosemia (CG) is a rare autosomal recessive metabolic disease caused by mutations in the galactose-1-phosphate uridyl transferase ( GALT ) gene. This study aim to identify pathogenic mutations underlying classic galactosemia in two Chinese families. Methods: We collected blood samples from two Chinese families and extracted genomic DNA. High-throughput sequencing, sanger sequencing, and bioinformatics analysis were used to inve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Based on the limitations and long timeliness of the aforementioned methods, gene testing technology has been widely used, especially with the mature high-throughput sequencing technology and rapid development, which can realize the accurate capture of target genes and the comprehensive analysis of high genetic heterogeneity diseases ( Li et al, 2020 ). It has lower operation costs, high-throughput, and fast operation and has reliable and stable results.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the limitations and long timeliness of the aforementioned methods, gene testing technology has been widely used, especially with the mature high-throughput sequencing technology and rapid development, which can realize the accurate capture of target genes and the comprehensive analysis of high genetic heterogeneity diseases ( Li et al, 2020 ). It has lower operation costs, high-throughput, and fast operation and has reliable and stable results.…”
Section: Discussionmentioning
confidence: 99%
“…Recessive mutations in the enzyme lead to the accumulation of Galactose 1-phosphate, which in turn, inhibits cellular metabolism leading to cellular toxicity. More than 200 mutations in the GALT gene have been linked to the MD [ 136 ], of which two have been reported in European and African lineages. A missense mutation presents itself as mild to severe cases of galactosemia of which four mutations have been identified as potential candidates for gene therapy [ 137 ].…”
Section: Galactosemiamentioning
confidence: 99%